[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Cardiac Ablation Market Research and Analysis, 2015-2022

May 2017 | | ID: G9D3065BB38EN
Orion Market Research Private Limited

US$ 3,495.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
MARKET INSIGHTS

Cardiac ablation is the process that is used for the treatment of heart rhythm problems. Cardiac ablation destroys the tissues in heart that triggers abnormal heart rhythm. Cardiac ablation generally uses catheters, which are inserted through arteries or vein in the body to deliver energy in heart to modify the tissue that causes arrhythmia. Cardiac ablation can also be performed via open heart surgery, however it is often done using catheters, which makes the procedure less invasive and reduces the recovery time. Although the procedure mainly depends upon the physical condition and malaise faced by patient. Cardiac ablation is widely used in the treatment of arrhythmias, atrial fibrillation, Wolff-Parkinson-White (WPW) syndrome, tachycardia, atrial flutter etc. these are the major application of cardiac ablation that is augmenting the demand of the procedure. The global cardiac ablation market is anticipated to grow with the CAGR of 12.6% during 2017-2022. Increasing geriatric population, rising prevalence of cardiovascular diseases are estimated to be the major factors that are augmenting the growth of the cardiac ablation market. Moreover, technological advancement in cardiac ablation and rise in the adoption of minimally invasive procedures with better medical imaging are also estimated to drive the growth of the cardiac ablation market. However, high cost containment measures taken by governments and changing healthcare reform in United States are estimated to be the major constraints in the growth of the market.

Global cardiac ablation market is studied in detail by segmenting the market on the basis of the crucial criteria such as on the basis of technology, and on the basis of applications. On the basis of technology, cardiac ablation market is further segmented into electrical ablation, microwave ablation, radiofrequency ablation, and ultrasound ablation. Further on the basis of applications, our market is bifurcated into cardiac rhythm management, open surgery and others.

GEOGRAPHY INSIGHTS

Global cardiac ablation market is further studied on the basis of the geographical regions that are contributing significantly towards the growth of the market. North America, Europe, Asia Pacific and Rest of the World are major geographical regions in the cardiac ablation market. North America is estimated to account for major share in the global cardiac ablation market owing to high prevalence of cardio vascular diseases in the region. Further well established healthcare infrastructure are also estimated to back the growth of the market in the region. Asia Pacific is estimated to be the fastest growing region during the forecast period owing to increasing healthcare expenditure in the region and rising geriatric population across the region.

COMPETITIVE INSIGHTS

Key players of the cardiac ablation market are AblaCor, Advanced Cardiac Therapeutics, Alcon Laboratories Inc., AngioDynamics, Atricure Inc., Baren-Boym, Bioscience Webster, Boston Scientific Corporation, Conmed Corporation, Covidien, Ethicon, Huainan Aofu Surgical Instruments, Medsphere, Medtronic Plc, Mount Sinai Corp., Olympus Corporation, St. Jude Medical Inc., ZenoMed and so on.

MARKET SEGMENTATION

1. GLOBAL CARDIAC ABLATION MARKET BY TECHNOLOGY
1.1. CRYOABLATION
1.2. ELECTRICAL ABLATION
1.3. MICROWAVE ABLATION
1.4. RADIOFREQUENCY ABLATION
1.5. ULTRASOUND ABLATION
2. GLOBAL CARDIAC ABLATION MARKET BY APPLICATION
2.1. CARDIAC RHYTHM MANAGEMENT
2.2. OPEN SURGERY
2.3. OTHERS

OMR REPORT COVERS:
  • Comprehensive research methodology of Global Cardiac Ablation Market
  • This report also includes detailed and extensive market overview with Analyst insights & key market trends.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Global Cardiac Ablation Market
  • Insights about market determinants which are stimulating the Global Cardiac Ablation Market
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
1. REPORT SUMMARY

1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
  1.2.1. BY SEGMENTS
  1.2.2. BY GEOGRAPHY
  1.2.3. BY STAKEHOLDERS

2. MARKET OVERVIEW AND INSIGHTS

2.1. DEFINITION
2.2. ANALYST INSIGHTS & CURRENT MARKET TRENDS
  2.2.1. KEY FINDINGS
  2.2.2. RECOMMENDATION
  2.2.3. CONCLUSION
2.3. REGULATIONS
  2.3.1. UNITED STATESI
  2.3.2. EUROPEAN UNION
  2.3.3. CHINA
  2.3.4. INDIA
  2.3.5. REST OF THE WORLD

3. MARKET DETERMINANT

3.1. MOTIVATORS
  3.1.1. INCREASING GERIATRIC POPULATION
  3.1.2. RISING PREVALENCE OF CARDIOVASCULAR DISEASES
  3.1.3. TECHNOLOGICAL ADVANCEMENTS
  3.1.4. RISE IN ADOPTION OF MINIMALLY INVASIVE PROCEDURES WITH BETTER MEDICAL IMAGING
3.2. RESTRAINTS
  3.2.1. HIGH COST CONTAINMENT MEASURE TAKEN BY GOVERNMENTS
  3.2.2. HEALTHCARE REFORMS IN US
3.3. OPPORTUNITIES
  3.3.1. EMERGENCE OF MICROWAVE ABLATION PROCEDURE IN CLINICAL TRIALS
  3.3.2. GROWING ADOPTION OF ABLATION IN CARDIOVASCULAR DISEASES TREATMENT

4. MARKET SEGMENTATION

4.1. GLOBAL CARDIAC ABLATION MARKET BY TECHNOLOGY
  4.1.1. CRYOABLATION
  4.1.2. ELECTRICAL ABLATION
  4.1.3. MICROWAVE ABLATION
  4.1.4. RADIOFREQUENCY ABLATION
  4.1.5. ULTRASOUND ABLATION
4.2. GLOBAL CARDIAC ABLATION MARKET BY APPLICATION
  4.2.1. CARDIAC RHYTHM MANAGEMENT
  4.2.2. OPEN SURGERY
  4.2.3. OTHERS

5. COMPETITIVE LANDSCAPE

5.1. KEY STRATEGY ANALYSIS
5.2. KEY COMPANY ANALYSIS

6. REGIONAL ANALYSIS

6.1. NORTH AMERICA
  6.1.1. UNITED STATES
  6.1.2. CANADA
  6.1.3. REST OF NORTH AMERICA
6.2. EUROPE
  6.2.1. UNITED KINGDOM
  6.2.2. FRANCE
  6.2.3. GERMANY
  6.2.4. ITALY
  6.2.5. SPAIN
  6.2.6. REST OF EUROPE
6.3. ASIA PACIFIC
  6.3.1. INDIA
  6.3.2. CHINA
  6.3.3. JAPAN
6.4. REST OF THE WORLD

7. COMPANY PROFILES

7.1. ABLACOR
  7.1.1. INTRODUCTION
  7.1.2. ABLACOR PRODUCT PORTFOLIO
  7.1.3. ABLACOR RECENT ACTIVITIES
7.2. ADVANCED CARDIAC THERAPEUTICS
  7.2.1. INTRODUCTION
  7.2.2. ADVANCED CARDIAC THERAPEUTICS PRODUCT PORTFOLIO
  7.2.3. ADVANCED CARDIAC THERAPEUTICS RECENT ACTIVITIES
7.3. ALCON LABORATORIES INC.
  7.3.1. INTRODUCTION
  7.3.2. ALCON LABORATORIES INC. PRODUCT PORTFOLIO
  7.3.3. ALCON LABORATORIES INC. RECENT ACTIVITIES
7.4. ANGIODYNAMICS
  7.4.1. INTRODUCTION
  7.4.2. ANGIODYNAMICS PRODUCT PORTFOLIO
  7.4.3. ANGIODYNAMICS RECENT ACTIVITIES
7.5. ATRICURE INC.
  7.5.1. INTRODUCTION
  7.5.2. ATRICURE INC. PRODUCT PORTFOLIO
  7.5.3. ATRICURE INC. RECENT ACTIVITIES
7.6. BAREN-BOYM
  7.6.1. INTRODUCTION
  7.6.2. BAREN-BOYM PRODUCT PORTFOLIO
  7.6.3. BAREN-BOYM RECENT ACTIVITIES
7.7. BIOSCIENCE WEBSTER
  7.7.1. INTRODUCTION
  7.7.2. BIOSCIENCE WEBSTER PRODUCT PORTFOLIO
  7.7.3. BIOSCIENCE WEBSTER RECENT ACTIVITIES
7.8. BOSTON SCIENTIFIC CORPORATION
  7.8.1. INTRODUCTION
  7.8.2. BOSTON SCIENTIFIC CORPORATION PRODUCT PORTFOLIO
  7.8.3. BOSTON SCIENTIFIC CORPORATION RECENT ACTIVITIES
7.9. CONMED CORPORATION
  7.9.1. INTRODUCTION
  7.9.2. CONMED CORPORATION PRODUCT PORTFOLIO
  7.9.3. CONMED CORPORATION RECENT ACTIVITIES
7.10. COVIDIEN
  7.10.1. INTRODUCTION
  7.10.2. COVIDIEN PRODUCT PORTFOLIO
  7.10.3. COVIDIEN RECENT ACTIVITIES
7.11. ETHICON
  7.11.1. INTRODUCTION
  7.11.2. ETHICON PRODUCT PORTFOLIO
  7.11.3. ETHICON RECENT ACTIVITIES
7.12. HUAINAN AOFU SURGICAL INSTRUMENTS
  7.12.1. INTRODUCTION
  7.12.2. HUAINAN AOFU SURGICAL INSTRUMENTS PRODUCT PORTFOLIO
  7.12.3. HUAINAN AOFU SURGICAL INSTRUMENTS RECENT ACTIVITIES
7.13. MEDSPHERE
  7.13.1. INTRODUCTION
  7.13.2. MEDSPHERE PRODUCT PORTFOLIO
  7.13.3. MEDSPHERE RECENT ACTIVITIES
7.14. MEDTRONICS PLC
  7.14.1. INTRODUCTION
  7.14.2. MEDTRONICS PLC PRODUCT PORTFOLIO
  7.14.3. MEDTRONICS PLC RECENT ACTIVITIES
7.15. MOUNT SINAI CORPORATION
  7.15.1. INTRODUCTION
  7.15.2. MOUNT SINAI CORPORATION PRODUCT PORTFOLIO
  7.15.3. MOUNT SINAI CORPORATION RECENT ACTIVITIES
7.16. OLYMPUS CORPORATION
  7.16.1. INTRODUCTION
  7.16.2. OLYMPUS CORPORATION PRODUCT PORTFOLIO
  7.16.3. OLYMPUS CORPORATION RECENT ACTIVITIES
7.17. ST. JUDE MEDICAL INC.
  7.17.1. INTRODUCTION
  7.17.2. ST. JUDE MEDICAL INC. PRODUCT PORTFOLIO
  7.17.3. ST. JUDE MEDICAL INC. RECENT ACTIVITIES
7.18. ZENOMED
  7.18.1. INTRODUCTION
  7.18.2. ZENOMED PRODUCT PORTFOLIO
  7.18.3. ZENOMED RECENT ACTIVITIES

LIST OF TABLES

TABLE #1 GLOBAL CARDIAC ABLATION MARKET RESEARCH AND ANALYSIS, BY APPLICATION 2015-2022 ($ MILLION)
TABLE #2 GLOBAL CRYOABLATION MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #3 GLOBAL ELECTRICAL ABLATION MARKET RESEARCH AND ANALYSIS,2015-2022 ($ MILLION)
TABLE #4 GLOBAL MICROWAVE ABLATION MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #5 GLOBAL RADIOFREQUENCY ABLATION MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #6 GLOBAL ULTRASOUND ABLATION MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #7 GLOBAL CARDIAC RHYTHM MANAGEMENT MARKET RESEARCH AND ANALYSIS, BY APPLICATION 2015-2022 ($ MILLION)
TABLE #8 GLOBAL OPEN SURGERY MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #9 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
TABLE #10 ABLACOR PRODUCT PORTFOLIO
TABLE #11 ABLACOR RECENT ACTIVITIES
TABLE #12 ADVANCED CARDIAC THERAPEUTICS PRODUCT PORTFOLIO
TABLE #13 ADVANCED CARDIAC THERAPEUTICS RECENT ACTIVITIES
TABLE #14 ALCON LABORATORIES INC. PRODUCT PORTFOLIO
TABLE #15 ALCON LABORATORIES INC. RECENT ACTIVITIES
TABLE #16 ANGIODYNAMICS PRODUCT PORTFOLIO
TABLE #17 ANGIODYNAMICS RECENT ACTIVITIES
TABLE #18 ATRICURE INC. PRODUCT PORTFOLIO
TABLE #19 ATRICURE INC. RECENT ACTIVITIES
TABLE #20 BAREN-BOYM PRODUCT PORTFOLIO
TABLE #21 BAREN-BOYM RECENT ACTIVITIES
TABLE #22 BIOSCIENCE WEBSTER PRODUCT PORTFOLIO
TABLE #23 BIOSCIENCE WEBSTER RECENT ACTIVITIES
TABLE #24 BOSTON SCIENTIFIC CORPORATION PRODUCT PORTFOLIO
TABLE #25 BOSTON SCIENTIFIC CORPORATION RECENT ACTIVITIES
TABLE #26 CONMED CORPORATION PRODUCT PORTFOLIO
TABLE #27 CONMED CORPORATION RECENT ACTIVITIES
TABLE #28 COVIDIEN PRODUCT PORTFOLIO
TABLE #29 COVIDIEN RECENT ACTIVITIES
TABLE #30 ETHICON PRODUCT PORTFOLIO
TABLE #31 ETHICON RECENT ACTIVITIES
TABLE #32 HUAINAN AOFU SURGICAL INSTRUMENTS PRODUCT PORTFOLIO
TABLE #33 HUAINAN AOFU SURGICAL INSTRUMENTS RECENT ACTIVITIES
TABLE #34 MEDSPHERE PRODUCT PORTFOLIO
TABLE #35 MEDSPHERE RECENT ACTIVITIES
TABLE #36 MEDTRONICS PLC PRODUCT PORTFOLIO
TABLE #37 MEDTRONICS PLC RECENT ACTIVITIES
TABLE #38 MOUNT SINAI CORPORATION PRODUCT PORTFOLIO
TABLE #39 MOUNT SINAI CORPORATION RECENT ACTIVITIES
TABLE #40 OLYMPUS CORPORATION PRODUCT PORTFOLIO
TABLE #41 OLYMPUS CORPORATION RECENT ACTIVITIES
TABLE #42 ST. JUDE MEDICAL INC. PRODUCT PORTFOLIO
TABLE #43 ST. JUDE MEDICAL INC. RECENT ACTIVITIES
TABLE #44 ZENOMED PRODUCT PORTFOLIO
TABLE #45 ZENOMED RECENT ACTIVITIES

LIST OF FIGURES

FIGURE #1 GLOBAL CRYOABLATION MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
FIGURE #2 GLOBAL ELECTRICAL ABLATION MARKET RESEARCH AND ANALYSIS,2015-2022 ($ MILLION)
FIGURE #3 GLOBAL MICROWAVE ABLATION MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
FIGURE #4 GLOBAL RADIOFREQUENCY ABLATION MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
FIGURE #5 GLOBAL ULTRASOUND ABLATION MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
FIGURE #6 GLOBAL CARDIAC RHYTHM MANAGEMENT MARKET RESEARCH AND ANALYSIS, BY APPLICATION 2015-2022 ($ MILLION)
FIGURE #7 GLOBAL OPEN SURGERY MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
FIGURE #8 GLOBAL OTHERS MARKET RESEARCH AND ANALYSIS, 2015-2022 ($ MILLION)
FIGURE #9 NORTH AMERICA MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #10 US MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #11 CANADA MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #12 EUROPEAN MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #13 UK MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #14 FRANCE MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #15 GERMANY MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #16 ITALY MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #17 SPAIN MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #18 ROE MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #19 ASIA PACIFIC MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #20 INDIA MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #21 CHINA MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #22 JAPAN MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #23 ROPAC MARKET RESEARCH AND ANALYSIS, 2015-2022
FIGURE #24 REST OF THE WORLD MARKET RESEARCH AND ANALYSIS, 2015-2022

COMPANIES MENTIONED

1. AblaCor
2. Advanced Cardiac Therapeutics
3. Alcon Laboratories Inc.
4. AngioDynamics
5. Atricure Inc.
6. Baren-Boym
7. Bioscience Webster
8. Boston Scientific Corporation
9. Conmed Corporation
10. Covidien
11. Ethicon
12. Huainan Aofu Surgical Instruments
13. Medsphere
14. Medtronic Plc
15. Mount Sinai Corp.
16. Olympus Corporation
17. St. Jude Medical Inc.
18. ZenoMed


More Publications